Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal α-toxin

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 1, 2012, Pages 41-49

  Kasraie, S ^a   Niebuhr, M ^a   Kopfnagel, V ^a   Dittrich Breiholz, O ^a   Kracht, M ^b   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

toxin; atopic dermatitis; chemokines; human macrophages; IP 10 CXCL10; MDC CCL22; psoriasis; Staphylococcus aureus

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAPHYLOCOCCUS ALPHA TOXIN;

ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BACTERIAL TOXINS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; CHEMOKINE CXCL10; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TH1 CELLS;

EID: 83555163834     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02710.x     Document Type: Article

References (35)

1. Leung DY, Bieber T,. Atopic dermatitis. Lancet 2003; 361: 151-160. (Pubitemid 36092023)
2. Werfel T,. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009; 129: 1878-1891.
3. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
4. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, et al., A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-361. (Pubitemid 28392277)
5. Bos JD, de Rie MA,. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999; 20: 40-46. (Pubitemid 29136549)
6. Homey B, Steinhoff M, Ruzicka T, Leung DY,. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006; 118: 178-189. (Pubitemid 43946487)
7. Pivarcsi A, Homey B,. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep 2005; 5: 284-290. (Pubitemid 41149708)
8. Homey B,. Chemokines and chemokine receptors as targets in the therapy of psoriasis. Curr Drug Targets Inflamm Allergy 2004; 3: 169-174. (Pubitemid 38832747)
9. Nickoloff BJ, Xin H, Nestle FO, Qin JZ,. The cytokine and chemokine network in psoriasis. Clin Dermatol 2007; 25: 568-573. (Pubitemid 350103656)
10. Breuer K, Kapp A, Werfel T,. Bacterial infections and atopic dermatitis. Allergy 2001; 56: 1034-1041. (Pubitemid 33020642)
11. Tomi NS, Kranke B, Aberer E,. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol 2005; 53: 67-72. (Pubitemid 40826696)
12. Dinges MM, Orwin PM, Schlievert PM,. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13: 16-34. (Pubitemid 30039341)
13. Breuer K, Wittmann M, Kempe K, Kapp A, Mai U, Dittrich-Breiholz O, et al., Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 2005; 35: 1088-1095. (Pubitemid 41603144)
14. Wichmann K, Uter W, Weiss J, Breuer K, Heratizadeh A, Mai U, et al., Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 2009; 161: 300-305.
15. Marples RR, Heaton CL, Kligman AM,. Staphylococcus aureus in psoriasis. Arch Dermatol 1973; 107: 568-570.
16. Balci DD, Duran N, Ozer B, Gunesacar R, Onlen Y, Yenin JZ,. High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis. Eur J Dermatol 2009; 19: 238-242.
17. McCormick TS, Stevens SR, Kang K,. Macrophages and cutaneous inflammation. Nat Biotechnol 2000; 18: 25-26. (Pubitemid 30041165)
18. Kasraie S, Niebuhr M, Werfel T,. Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins. Allergy 2010; 65: 712-721.
19. Hanifin JM, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.): 44-47.
20. Purwar R, Wittmann M, Zwirner J, Oppermann M, Kracht M, Dittrich-Breiholz O, et al., Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions. J Immunol 2006; 177: 4444-4450. (Pubitemid 44469773)
21. Wittmann M, Zeitvogel J, Wang D, Werfel T,. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J Allergy Clin Immunol 2009; 124: 81-89.
22. Qi XF, Kim DH, Yoon YS, Jin D, Huang XZ, Li JH, et al., Essential involvement of cross-talk between IFN-gamma and TNF-alpha in CXCL10 production in human THP-1 monocytes. J Cell Physiol 2009; 220: 690-697.
23. Purwar R, Werfel T, Wittmann M,. IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. J Invest Dermatol 2006; 126: 1043-1051.
24. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, Bhakdi S,. Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 1994; 62: 1304-1312. (Pubitemid 24110824)
25. Bhakdi S, Muhly M, Korom S, Hugo F,. Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immun 1989; 57: 3512-3519. (Pubitemid 19259885)
26. Suttorp N, Seeger W, Zucker-Reimann J, Roka L, Bhakdi S,. Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin. Infect Immun 1987; 55: 104-110. (Pubitemid 17220372)
27. Grimminger F, Rose F, Sibelius U, Meinhardt M, Potzsch B, Spriestersbach R, et al., Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. J Immunol 1997; 159: 1909-1916. (Pubitemid 127484180)
28. Suttorp N, Habben E,. Effect of staphylococcal alpha-toxin on intracellular Ca2+ in polymorphonuclear leukocytes. Infect Immun 1988; 56: 2228-2234.
29. Villagomez MT, Bae SJ, Ogawa I, Takenaka M, Katayama I,. Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis. Br J Dermatol 2004; 150: 910-916. (Pubitemid 38903523)
30. Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Giannetti A, et al., Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001; 107: 871-877. (Pubitemid 32436921)
31. Holzberg D, Knight CG, Dittrich-Breiholz O, Schneider H, Dörrie A, Hoffmann E, et al., Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes. J Biol Chem 2003; 278: 40213-40223. (Pubitemid 37248589)
32. Martinon F, Mayor A, Tschopp J,. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27: 229-265.
33. Craven RR, Gao X, Allen IC, Gris D, Bubeck WJ, McElvania-Tekippe E, et al., Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS ONE 2009; 4: e7446.
34. Narbutt J, Lesiak A, Sysa-Jedrzeiowska A, Zakrzewski M, Bogaczewicz J, Stelmach I, et al., The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis. Mediators Inflamm 2009; 2009: 269541.
35. Yamashita T, Akamatsu H, Tomitaka A, Ogawa Y, Sugawara N, Matsunaga K,. IP-10 in atopic dermatitis. Allergy 2003; 58: 261. (Pubitemid 36609368)